Copyright
©2010 Baishideng.
World J Gastroenterol. Jul 21, 2010; 16(27): 3406-3410
Published online Jul 21, 2010. doi: 10.3748/wjg.v16.i27.3406
Published online Jul 21, 2010. doi: 10.3748/wjg.v16.i27.3406
Table 1 Demographic data and mean fecal calprotectin concentrations of the different study groups (mean ± SD)
| Groups | n | Sex (M/F) | Age (yr) | FCCs (μg/g) |
| Patients | 61 | 28/33 | 49.64 ± 13.80 | 28.25 ± 23.43 |
| Active gastritis | 35 | 15/20 | 49.66 ± 14.15 | 29.70 ± 21.26 |
| Mild | 15 | 6/9 | 48.07 ± 14.56 | 31.44 ± 22.55 |
| Moderate | 10 | 7/3 | 47.60 ± 13.72 | 31.08 ± 23.68 |
| Marked | 10 | 2/8 | 53.30 ± 14.64 | 26.57 ± 17.66 |
| Non active gastritis | 26 | 13/13 | 49.90 ± 13.61 | 25.97 ± 22.55 |
| Healthy controls | 74 | 32/42 | 45.93 ± 12.42 | 31.20 ± 19.18 |
- Citation: Montalto M, Gallo A, Ianiro G, Santoro L, D’Onofrio F, Ricci R, Cammarota G, Covino M, Vastola M, Gasbarrini A, Gasbarrini G. Can chronic gastritis cause an increase in fecal calprotectin concentrations? World J Gastroenterol 2010; 16(27): 3406-3410
- URL: https://www.wjgnet.com/1007-9327/full/v16/i27/3406.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i27.3406